喹咱替尼(AC220)是一种小分子受体酪氨酸激酶抑制剂,目前正在由Ambit Biosciences开发用于治疗急性髓性白血病.它的分子靶点是FLT3,也称为CD135,它是原癌基因.
-
97% CAS No.:26278-79-5 -
SKU-Pack Size Availability Price（￥） Quantity R167221-1g In-Stock(Shanghai or CA Irwindale) R167221-5g In-Stock(Shanghai or CA Irwindale) R167221-10g In-Stock(Shanghai or CA Irwindale) R167221-25g In-Stock(Shanghai or CA Irwindale) R167221-100g In-Stock(Shanghai or CA Irwindale)